Lupin 2024

Camber launches generic Pepcid

Print Friendly, PDF & Email

PISCATAWAY, N.J.– Camber Pharmaceuticals announced the addition of famotidine powder for oral suspension, USP to its current portfolio.

Famotidine powder for oral suspension, USP is indicated:

In adults for the treatment of:

  • active duodenal ulcer (DU).
  • active gastric ulcer (GU).
  • symptomatic nonerosive gastroesophageal reflux disease (GERD).
  • erosive esophagitis due to GERD, diagnosed by biopsy.
  • treatment of pathological hypersecretory conditions (e.g., Zollinger-Ellison syndrome, multiple endocrine neoplasias).
  • reduction of the risk of DU recurrence.

In pediatric patients 1 year of age and older for the treatment of:

  • peptic ulcer disease.
  • GERD with or without esophagitis and ulcerations.

In pediatric patients from birth to less than 1 year of age for the treatment of:

  • GERD.

Famotidine 40 mg/5 mL powder for oral suspension, USP is available in a bottle to make 50 mL when reconstituted as directed.


Comments are closed.